IRLAB Therapeutics AB (OSTO:IRLAB A) Market Cap : kr803.96 Mil (As of May. 27, 2024)

View and export this data going back to 2017. Start your Free Trial

What is IRLAB Therapeutics AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). IRLAB Therapeutics AB's share price for the quarter that ended in Mar. 2024 was kr15.6. IRLAB Therapeutics AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 51.95 Mil. Therefore, IRLAB Therapeutics AB's market cap for the quarter that ended in Mar. 2024 was kr810.39 Mil.

IRLAB Therapeutics AB's quarterly market cap increased from Sep. 2023 (kr382.79 Mil) to Dec. 2023 (kr389.01 Mil) and increased from Dec. 2023 (kr389.01 Mil) to Mar. 2024 (kr810.39 Mil).

IRLAB Therapeutics AB's annual market cap declined from Dec. 2021 (kr2,276.93 Mil) to Dec. 2022 (kr1,986.56 Mil) and declined from Dec. 2022 (kr1,986.56 Mil) to Dec. 2023 (kr389.01 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. IRLAB Therapeutics AB's Enterprise Value for Today is kr758.43 Mil.

IRLAB Therapeutics AB Market Cap Historical Data

The historical data trend for IRLAB Therapeutics AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRLAB Therapeutics AB Market Cap Chart

IRLAB Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

1,577.62

2,036.93

2,276.93

1,986.56

389.01

IRLAB Therapeutics AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															574.70	449.18	382.79	389.01	810.39

Competitive Comparison of IRLAB Therapeutics AB's Market Cap

For the Biotechnology subindustry, IRLAB Therapeutics AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IRLAB Therapeutics AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IRLAB Therapeutics AB's Market Cap distribution charts can be found below:

* The bar in red indicates where IRLAB Therapeutics AB's Market Cap falls into.

IRLAB Therapeutics AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

IRLAB Therapeutics AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	kr7.5	*	51.8684
	=	kr389.01

IRLAB Therapeutics AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	kr15.6	*	51.9482
	=	kr810.39

IRLAB Therapeutics AB (OSTO:IRLAB A) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

IRLAB Therapeutics AB Market Cap Related Terms

Thank you for viewing the detailed overview of IRLAB Therapeutics AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

IRLAB Therapeutics AB (OSTO:IRLAB A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IRLAB Therapeutics AB (OSTO:IRLAB A) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

6IRA:Germany

Address

Arvid Wallgren Backe 20, Goteborg, SWE, 413 46

Website

https://www.irlab.se

IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.

IRLAB Therapeutics AB (OSTO:IRLAB A) Headlines

No Headlines